Bio Nano Consulting Targets the US Life Science Market
Tuesday 5th
San Francisco 8:30 – 10:30 Breakfast Event ‘Nanotechnology in Drug Discovery’ 11:30 – 13:30 Radio Interviews with Dr Moira Gunn on BioTech Nation on NPR
Thursday 7th
Boston 16:00 – 19:30 Event: ‘Nanotechnology in Drug Discovery and Development’, British Consulate General, 1 Main St, Cambridge MA 20:30 Speakers & ‘special guest’ dinner. Top of the Hub, Prudential Centre, Boston. Proposed Guests: Dr Bruce Pratt, Genzyme; Dan Passerie, CEO Curis Inc; Pepper Denman, GE Healthcare; Dr Gunther Winkler, Biogen Idec.
Commenting on the tour, Dr. David Sarphie, BNC’s CEO commented: “BNC has successfully delivered a number of contracts in the US where UK innovation and knowledge has helped solve some real-world problems for US clients. We see significant opportunities for US expansion due to the increasing pressures to reduce costs, increase speed to market and decrease attrition rates.“
He added; “The US visit to San Francisco and Boston aims to highlight to a wider life science audience how nanotechnology can help improve product development. This includes increasing the knowledge of how drugs really interact with their targets, by solving formulation problems to increase bioavailability, and to promoting BNC’s unique services in accessing academic research and expertise combined with a strong commercial imperative. We believe that BNC’s services provide a win-win scenario by solving client problems and also ensuring academic expertise has commercial relevance.”
About Bio Nano Consulting
Bio Nano Consulting is a joint venture of Imperial College London and University College London that specialises in delivering innovative solutions to industry across the life sciences and technology sectors. We are the first consultancy in Europe to focus on the intersection between bio and nanotechnology, providing product development and strategic consultancy, project management and access to state of the art instrumentation and world-leading researchers. Through its partner organisations of UCL, Imperial College, the National Physical Laboratory, and now the School of Pharmacy, University of London, BNC offers services to the biomedical, healthcare and technology industries.
For more information, please contact Tristan Jervis or Alex Heeley on 00 44 207 861 3838 or e-mail t.jervis@defacto.com.